COVID-19 has affected the delivery of routine health care and eroded social safety nets around the world—and that has been especially true for vulnerable communities in Eastern Europe, Central Asia, and the Balkans.

Health systems are struggling with the tension between  COVID-19’s immediate demands and the long-term struggle against tuberculosis—one of the deadliest infectious diseases.  

Generally, tuberculosis kills more men than women.  

Tuberculosis is a curable illness, yet it is the top infectious disease killer worldwide. South Africa bears the brunt—the country lost 64,000 people to TB in 2019 alone.   Until recently, TB patients in South Africa—who wear face masks during treatment—also shouldered…

A new algorithm from University College London researchers could boost the tricky business of determining a person’s risk of developing active TB.

It’s well known that infants and elderly people are particularly vulnerable to infectious diseases—but what happens in between those age extremes?  

The world needs to hurry up if global targets to stamp out tuberculosis—the world’s deadliest infectious killer—are going to be met, according to the WHO’s latest report.  

As high school students in St. Louis, Missouri, we reaped the benefits of global health security every time we sat in classrooms with our friends. Now that sense of safety has evaporated, and students everywhere are living the consequences of inadequate health policies.…

In the massive push to get a COVID-19 vaccine to market, drugmakers are looking to do within a year what often takes a decade or more, Bloomberg reports.   70+ coronavirus vaccine candidates are in the works worldwide—3 of them have reached the human trial stage.  

In the global arsenal for nearly a century, the vaccine against tuberculosis could provide some protection against COVID-19, Euronews reports.